Phoenix Group Holdings PLC — Board/Management Information 2015

Apr 23, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1254L

Phoenix Group Holdings

23 April 2015

Phoenix Group Holdings (the "Company")

In compliance with Listing Rule 9.6.14, the Company announces that with effect from 21 April 2015, Rene-Pierre Azria, a non-executive director of the Company, has been appointed a director of Immune Pharmaceuticals Inc, whose shares are listed in the USA on the NASDAQ.

Enquiries:

Media Neil Bennett, Maitland Peter Ogden, Maitland + 44 (0) 20 7379 5151	Investors Sam Perowne, Head of Investor Relations, Phoenix Group +44 (0) 203 735 0021

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNKMGZDGFZGKZM